Wockhardt will deepen its novel antibiotics pipeline over the next five years and focus on building a biosimilar business for ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corp. (XOM), ...

A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s ...

Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

High-yielding dividend stocks can be great investments to hold on to in your portfolio, but only if they're safe. Betting on a high yield can be dangerous because if it ends up getting cut, you could ...

Summary of Changes - In the fall of 2024, several pharmaceutical companies – specifically, Eli Lilly and Company, Sanofi-Aventis U.S. LLC, ...

Shares of Bristol Myers Squibb Co. BMY shed 2.36% to $59.55 Tuesday, on what proved to be an all-around mixed trading session ...

The FDA as we’ve known it is finished, with most of the leaders with institutional knowledge and a deep understanding of ...

A federal appeals court on Tuesday affirmed the dismissal of a dental surgeon’s suit alleging Bristol-Myers Squibb Co.'s leukemia drug Sprycel caused retinal bleeding and vision loss.

Learn more about whether Bristol-Myers Squibb Company or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Learn more about whether Bristol-Myers Squibb Company or Corcept Therapeutics Incorporated is a better investment based on ...